Gene Therapy On Cardiovascular Disease and Forecast Market

List of Tables
Table 1. Gene Therapy On Cardiovascular Disease Market Opportunities & Trends in Global Market
Table 2. Gene Therapy On Cardiovascular Disease Market Drivers in Global Market
Table 3. Gene Therapy On Cardiovascular Disease Market Restraints in Global Market
Table 4. Key Players of Gene Therapy On Cardiovascular Disease in Global Market
Table 5. Top Gene Therapy On Cardiovascular Disease Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Gene Therapy On Cardiovascular Disease Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Gene Therapy On Cardiovascular Disease Revenue Share by Companies, 2020-2025
Table 8. Global Companies Gene Therapy On Cardiovascular Disease Product Type
Table 9. List of Global Tier 1 Gene Therapy On Cardiovascular Disease Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy On Cardiovascular Disease Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Gene Therapy On Cardiovascular Disease Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2026-2032
Table 30. Biogen Corporate Summary
Table 31. Biogen Gene Therapy On Cardiovascular Disease Product Offerings
Table 32. Biogen Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 33. Biogen Key News & Latest Developments
Table 34. Novartis Corporate Summary
Table 35. Novartis Gene Therapy On Cardiovascular Disease Product Offerings
Table 36. Novartis Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 37. Novartis Key News & Latest Developments
Table 38. Gilead Sciences Corporate Summary
Table 39. Gilead Sciences Gene Therapy On Cardiovascular Disease Product Offerings
Table 40. Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 41. Gilead Sciences Key News & Latest Developments
Table 42. Sarepta Therapeutics Corporate Summary
Table 43. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Offerings
Table 44. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 45. Sarepta Therapeutics Key News & Latest Developments
Table 46. Alnylam Pharmaceuticals Corporate Summary
Table 47. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Offerings
Table 48. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 49. Alnylam Pharmaceuticals Key News & Latest Developments
Table 50. Amgen Corporate Summary
Table 51. Amgen Gene Therapy On Cardiovascular Disease Product Offerings
Table 52. Amgen Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 53. Amgen Key News & Latest Developments
Table 54. Spark Therapeutics Corporate Summary
Table 55. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Offerings
Table 56. Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 57. Spark Therapeutics Key News & Latest Developments
Table 58. Akcea Therapeutics Corporate Summary
Table 59. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Offerings
Table 60. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 61. Akcea Therapeutics Key News & Latest Developments
Table 62. bluebird bio Corporate Summary
Table 63. bluebird bio Gene Therapy On Cardiovascular Disease Product Offerings
Table 64. bluebird bio Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 65. bluebird bio Key News & Latest Developments
Table 66. Sunway Biotech Corporate Summary
Table 67. Sunway Biotech Gene Therapy On Cardiovascular Disease Product Offerings
Table 68. Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 69. Sunway Biotech Key News & Latest Developments
Table 70. SIBIONO Corporate Summary
Table 71. SIBIONO Gene Therapy On Cardiovascular Disease Product Offerings
Table 72. SIBIONO Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 73. SIBIONO Key News & Latest Developments
Table 74. AnGes Corporate Summary
Table 75. AnGes Gene Therapy On Cardiovascular Disease Product Offerings
Table 76. AnGes Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 77. AnGes Key News & Latest Developments
Table 78. Orchard Therapeutics Corporate Summary
Table 79. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Offerings
Table 80. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 81. Orchard Therapeutics Key News & Latest Developments
Table 82. Human Stem Cells Institute Corporate Summary
Table 83. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Offerings
Table 84. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue (US$, Mn) & (2020-2025)
Table 85. Human Stem Cells Institute Key News & Latest Developments


List of Figures
Figure 1. Gene Therapy On Cardiovascular Disease Product Picture
Figure 2. Gene Therapy On Cardiovascular Disease Segment by Type in 2024
Figure 3. Gene Therapy On Cardiovascular Disease Segment by Application in 2024
Figure 4. Global Gene Therapy On Cardiovascular Disease Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Gene Therapy On Cardiovascular Disease Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Gene Therapy On Cardiovascular Disease Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Gene Therapy On Cardiovascular Disease Revenue in 2024
Figure 9. Segmentation by Type � Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Gene Therapy On Cardiovascular Disease Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Gene Therapy On Cardiovascular Disease Revenue Market Share, 2020-2032
Figure 13. By Region - Global Gene Therapy On Cardiovascular Disease Revenue Market Share, 2020-2032
Figure 14. By Country - North America Gene Therapy On Cardiovascular Disease Revenue Market Share, 2020-2032
Figure 15. United States Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Gene Therapy On Cardiovascular Disease Revenue Market Share, 2020-2032
Figure 19. Germany Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 20. France Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Gene Therapy On Cardiovascular Disease Revenue Market Share, 2020-2032
Figure 27. China Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 31. India Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Gene Therapy On Cardiovascular Disease Revenue Market Share, 2020-2032
Figure 33. Brazil Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Gene Therapy On Cardiovascular Disease Revenue Market Share, 2020-2032
Figure 36. Turkey Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Gene Therapy On Cardiovascular Disease Revenue, (US$, Mn), 2020-2032
Figure 40. Biogen Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Novartis Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Amgen Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. bluebird bio Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. SIBIONO Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. AnGes Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2020-2025)